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CObjective: The National Institutes of Health Patient-Reported Out-
comes Measurement Information System (PROMIS) roadmap initiative
is a cooperative group program of research designed to develop, eval-
uate, and standardize item banks to measure patient-reported out-
comes relevant across medical conditions. The objective of the current
study was to assess feasibility and evaluation of the construct validity
of PROMIS item banks versus legacy measures in an observational
study in systemic sclerosis (SSc). We hypothesized that the PROMIS
item banks can be administered in a clinical setting if there is adequate
staff support without disrupting the flow of clinic. Methods: Patients
with SSc in a single academic center completed computerized adaptive
test (CAT) administered PROMIS item banks during the clinic visit and
legacy measures (using paper and pencil). The construct validity of
PROMIS items was evaluated by examining correlations with corre-
sponding legacy measures using multitrait-multimethod analysis.
Results: Participants consisted of 143 SSc patients with an average age O
r of
ology
al So
oi:10.1016/j.jval.2011.08.006f 51.5 years; 71% were female and 68% were white. The average num-
er of items completed for each CAT-administered item bank ranged
rom5 to 8 (69 CAT items per patient), and the average time to complete
ach CAT-administered item bank ranged from 48 seconds to 1.9 min-
tes per patient (average time 11.9minutes/per patient for 11 banks).
ll correlations between PROMIS domains and respective legacy mea-
ures were large and in the hypothesized direction (ranged from 0.61 to
.82). Conclusion: Our study supports the construct validity of the
AT-administered PROMIS item banks and shows that they can be
dministered successfully in a clinic with support staff. Future studies
hould assess the feasibility of PROMIS item banks in a busy clinical
ractice.
eywords: construct validity, health-related quality of life, systemic
clerosis, PROMIS.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The National Institutes of Health (NIH) patient-reported outcomes
measurement information system (PROMIS) roadmap initiative
(www.nihpromis.org) is a cooperative research program designed to
develop, evaluate, and standardize item banks to measure patient-
reportedoutcomes (PROs) acrossdifferentmedical conditionsaswell
as theUSpopulation [1]. Thegoal of PROMIS is todevelop reliable and
alid itembanksusing item response theory (IRT) that canbe admin-
stered as computerized adaptive tests (CAT) [1–3]. CAT selects the
ost informative questions from an item bank on the basis of a per-
on’s previous responses; this process determines an individualized
core using a minimum number of questions while preserving pre-
ision. Items for 11 domains were developed during the first wave of
ROMIS for administration to adults [1].We evaluated these items in
* Address correspondence to: Dinesh Khanna, Associate Professo
niversity ofMichigan Scleroderma Program, Division of Rheumat
uite 2500, SPC 5753, P.O. Box 481, Ann Arbor, MI USA 48106.
E-mail: khannad@med.umich.edu.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.a cross-sectional study of patients with systemic sclerosis (sclero-
derma; SSc) from a single center.
Scleroderma, meaning thickened skin, is a rare disease that
affects 300 to 700 people per million population [4]. Scleroderma
manifests itself in several forms, including localized disease, over-
lap syndromes, scleroderma-like diseases, and systemic sclerosis
(SSc) [5]. SSc is an autoimmune disease that includes thickening of
the skin and internal organ involvement (heart, lung, gastrointes-
tinal, and kidney involvement). People with SSc have both skin
hardening and internal involvement; depending on the extent of
skin involvement, SSc is divided into limited SSc and diffuse SSc
[5]. Patients with limited SSc generally have a more favorable out-
come, with a 5-year survival as high as 86% [6]. Diffuse SSc is
characterized by rapid skin thickening and potentially severe pul-
monary, cardiac, renal, and gastrointestinal involvement occur-
Medicine, Marvin and Betty Danto Research Professor, Director,
/Dept. of InternalMedicine, 24 Frank LloydWright Drive, LobbyM,
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
w129V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 1 2 8 – 1 3 4ring in the first 3 to 5 years of disease and may be associated with
poor survival [5].
SSc has no effective treatment or cure, and patients are chal-
lenged by health-related quality of life (HRQOL) impacts such as
pain, disfigurement, disability, and feelings of helplessness [7–9].
In this study we sought to assess the feasibility of administrating
PROMIS item banks in an academic clinical setting and evaluate
the construct validity of PROMIS domains versus legacy measures
in an observational study of patients with SSc. We hypothesized
that the PROMIS item banks can be administered in a clinical set-
ting with adequate staff support without disrupting the flow of
clinic, and that the item banks would be highly correlated with
corresponding legacy instruments.
Methods
Patients
We recruited SSc patients receiving care in the UCLA scleroderma
program to serve as participants in the UCLA scleroderma quality
of life study. The studywas launched to assess psychometric prop-
erties (including minimally important differences) of legacy in-
struments used in SSc research [10,11]. Adult patients (18 years)
ith a diagnosis of SSc were included in the study [12]. Patients
with SSc were further divided into limited SSc, diffuse SSc, and
overlap syndrome. Limited SSc is defined as skin thickening distal,
but not proximal, to the knees and elbows, with or without facial
involvement; diffuse SSc is defined as skin thickening distal and
proximal, to the knees and elbows, with or without facial involve-
ment; and overlap syndrome is defined as patients with SSc and
another rheumatic disease (such as inflammatory myositis or
rheumatoid arthritis).
Study protocol
This study is a single center observational studywhere patientswith
SSc are invited to participate during their clinic visits over a period of
1 year (2009–2010). The current analysis reports the baseline data.
The UCLA scleroderma clinic is a weekly clinic where patients with
SSc are seen by three rheumatologistswith SSc expertise (D.K., D.E.F,
and P.J.C). Each clinician has two dedicated rooms assigned to him
and each examines 10 to 12 patients at each clinic (total of 30–36
patients). SSc patients with new (60-minute time slot) or follow-up
(30-minute time slot) consultations were approached at the time of
their scheduled clinic visit by the front desk staff or the nurse and
invited to participate in the study. If a patient was interested, he or
she was handed a UCLA Institutional Review Board-approved writ-
ten consent and Health Insurance Portability and Accountability Act
(HIPAA) forms. After completion of the clinical visit, the clinician
introduced the study to the patient.
Because one of the objectives of the study was to assess the
feasibility of administrating PROMIS item banks in a clinical set-
ting, we invited all patients to participate irrespective of their dis-
abilities. If the patientwas interested, she or he signed the consent
andHIPAA forms and the study coordinator directed the patient to
the PROMIS Assessment Center (www.assessmentcenter.net) to
complete the 11 item banks (discussed below) [13]. Assessment
Center is software supported by PROMIS that is used for CAT-
administered item banks. Patients completed the PROMIS items in
the examination room and the coordinator was available in the
clinic area for questions about the Assessment Center or items.
For patients with physical disabilities, the coordinator was also
encouraged to help the patient respond to the items. In themean-
time, the physician used the other assigned examination room to
examine the next patient. The item banks were completed using a
dedicated desktop computer in each exam room so that patients
had complete privacy. After PROMIS bankswere administered, thepatient was asked to complete the legacy instruments in the same
room. The majority of the legacy measures were administered
using the traditional paper-and-pencil method during the clinic
visit; in rare instances they were completed at home and returned
within 1 week using pre-stamped envelopes.
Measures
PROMIS version 1.0 item banks including anger, anxiety, depres-
sion, fatigue, pain behavior, pain interference, physical function,
sleep disturbance, sleep impairment, satisfaction with participa-
tion in social roles, and satisfaction with participation in discre-
tionary social activities were administered as CATs (available at:
www.nihpromis.org). With the exception of physical function,
which does not include a time frame, and the social health banks
that reference “lately,” all item banks reference the past 7 days.
Items were written at a sixth grade reading level or below.
All items were evaluated with the Lexile Analyzer to assess read-
ability. The Lexile Analyzer gives an approximate reading level for
the item based on the commonness of words in the item and the
complexity of the syntax [14].
All banks other than pain behavior use a rating scale with five
response options thatmost commonly reflect intensity (e.g., not at
all, a little bit, somewhat, quite a bit, verymuch) or frequency (e.g.,
never, rarely, sometimes, often, always). Pain behavior has six
response options and includes a “had no pain” response option as
well. All PROMIS instruments are scored using a T score metric so
that the mean in the US general population is 50 with a standard
deviation (SD) of 10. Higher scores reflect more of what is being
measured. Therefore, high scores for physical and social function
are desirable, whereas high symptom scores are undesirable.
CATs were set to administer enough items to achieve a standard
error (SE)  0.30 (corresponding to reliability  0.90) after a mini-
mum of five items were administered per bank. Each CAT was
concluded regardless after 20 itemswere administered orwhen all
the items were administered (for social satisfaction discretionary,
social-satisfaction roles, sleep-impairment, the number of items
range from 12–16 in the item bank) even if the SE criterion was not
met. Additional information about the banks is available at:
www.nihpromis.org.
Legacy instruments were also included in this study. Legacy
instruments are the most widely used survey instruments to as-
sess a particular patient-reported outcome; considered the state-
of-the-science prior to PROMIS. Legacy instruments included the
short form 36 health survey (SF-36) version 2 [15], health assess-
ment questionnaire-disability index (HAQ-DI) [16],10-item center
for epidemiologic studies depression (CESD) scale [17], functional
assessment of chronic illness therapy (FACIT)-fatigue [18], and
medical outcomes study (MOS) sleep scale [19]. These legacy in-
struments were chosen as they have been endorsed by the out-
comes measures in rheumatology (OMERACT) [11,20] and/or re-
cently evaluated in SSc [21–23].
The SF-36 version 2 is a generic health status measure consist-
ing of 36 items assessing eight scales [15]. The eight scales are
summarized into physical component summary (PCS) andmental
component summary (MCS) scores. The scales and summary
scores are normalized to the US general population, for whom the
mean score is 50 and the SD is 10.Weused the 4-week recall period
version of the SF-36 v.2.
The HAQ-DI is an arthritis-targeted measure intended for as-
sessing functional ability in arthritis [16,24]. It is a self-adminis-
tered 20-question instrument that assesses a patient’s level of
functional ability and includes questions that involve both upper
and lower extremities. The HAQ-DI score ranges from 0 (no dis-
ability) to three (severe disability). It has a 7-day recall period.
Depressive symptoms were measured with the 10-item CESD-
10) scale [17]. The CESD-10 uses a 4-point categorical response
scale (range 0 to 30) with higher scores representing greater de-
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pressive symptoms. It has a 7-day recall period.
The FACIT-fatigue is a 13-item questionnaire that assesses
self-reported fatigue and its impact upon daily activities and func-
tion over the past 7 days. The range of possible scores is 0 to 52,
with lower scores reflecting more fatigue.
The MOS sleep scale [19] yields a sleep problems index and six
scale scores. Answers were based on a retrospective assessment
over the past 4 weeks. Quantity of sleep is scored as the average
hours slept per night. The other scales and 9-item sleep problem
index are scored on a 0 to 100 possible range, and higher scores
indicate more of the concept being measured.
Analysis
Mean scores, SD, ranges, and percentages of respondents scoring
the minimum (floor) and maximum (ceiling) possible scores were
calculated to evaluate scale score distributions for PROMIS and
legacy instruments. For easy interpretability, floor effect is pre-
sented as “worst” possible score and ceiling as “best” possible ir-
respective of the direction of the scale. To obtain the minimum
andmaximum scores for the SF-36 scales, we calculated theworst
possible and best possible scores for each scale. For the PCS and
MCS we multiplied the factor scoring coefficients for the eight
scale scores by z-scores that represented either the minimum or
maximum scale score possible and transformed linearly to T score
metric using the formula: (z10)  50. To get the maximum possi-
le PCS and MCS scores, we used the minimum scale score if the
coring coefficient was negative and the maximum scale score if
he coefficient was positive. For PROMIS item banks, we calculated
heworst possible and best possible scores for each scale using the
hole item bank.
Internal consistency reliability for legacy items was estimated
sing Cronbach’s alpha [25]. An alpha  0.70 is considered satis-
Table 1 – Descriptive statistics of the legacy instruments in
Legacy domains
(possible score range)
Scores
N Mean Median M
CESD (0–30)* 142 8.7 8
HAQ-DI (0–3)* 142 0.9 0.9
SF-36 v.2 physical functioning
(14.9–57.0)
143 35.4 36
SF-36 v.2 role limitations—
physical (17.7–56.9)
141 37.8 37.3
SF-36 v.2 bodily pain
(19.9–62.1)
142 45.2 46.1
SF-36 v.2 general health
(16.2–63.9)
143 43.6 43.4
SF-36 v.2 vitality (20.9–70.8) 143 43.8 45.8
SF-36 v.2 role
limitations–emotional
(9.2–55.9)
141 43.7 48.1
SF-36 v.2 social functioning
(13.2–56.8)
143 42.6 45.9
SF-36 v.2 emotional well
being (7.8–64.1)
143 47.2 50
SF-36 v.2 PCS (12.9–58.9) 140 38.2 37.7
SF-36 v.2 MCS (6.2–69.4) 140 47.8 50.2
FACIT-fatigue (0–52) 143 31.6 31
MOS sleep problem index (9
items)*
142 39.4 40.3
Floor effect is presented as “worst” possible score and ceiling as “bes
CESD, center for epidemiologic studies depression (10-item scale);
HAQ-DI, health assessment questionnaire-disability index; MOS, me
* Higher scores indicate poor health-related quality of life (for other domaactory for group comparisons [26]. We also assessed if there were
ifferences in socio-demographics, type of SSc or disease duration
n patients falling in the first versus fourth quartiles and  56
tems versus  56 items for total CAT-items completed.
Multitrait-multimethod analysis
The construct validity of PROMIS measures was evaluated by ex-
amining correlations with corresponding legacymeasures using a
computer program for analyzing a multitrait-multimethod
(MTMM) matrix. Construct validity is supported in MTMM analy-
ses when the highest correlations are found for different methods
of assessing the same domain (validity diagonals) andweaker cor-
relations among measures of different domains [26]. The six
PROMIS domains selected for analysis were depression, fatigue,
pain behavior, physical function, sleep disturbance, and satisfac-
tionwith participation in discretionary social activities. This is due
to the fact that only six PROMIS domains had corresponding legacy
scales administered in the study. The corresponding legacy scales
were the CESD-10, FACIT-fatigue, SF-36 bodily pain, SF-36 physical
functioning, MOS 9-item sleep problem index, and SF-36 social
functioning, respectively. Analyses were also repeated by replac-
ing HAQ-DI for SF-36 physical functioning and SF-36 vitality for
FACIT-fatigue. We hypothesized correlation coefficients for valid-
ity diagonals of0.50 (a large effect size [27]) and that these would
be significantly larger than off-diagonal correlations.
Results
We recruited 143 patients with SSc. The average (SD) age was 51.5
(14.7) years; 117 (71%) were female and 94 (68%) were white. The
mean (SD) disease duration was 7.5 (8.2) years. Seventy-six (55%)
had limited SSc, 55 (39%) had diffuse SSc, and 9 (6%) had overlap
ing reliability and floor/ ceiling effects.
Cronbach’s
alpha
Floor Ceiling
um Maximum N % N %
27 0.84 0 0 8 6.0
2.6 0.87 0 0 14 10.0
57 0.92 5 3.5 6 4.2
56.9 0.96 13 9.2 15 10.6
62.1 0.92 1 0.7 19 13.4
55.3 0.73 0 0.0 0 0.0
70.8 0.88 1 0.7 3 2.1
55.9 0.94 9 6.4 58 41.1
56.8 0.89 1 0.7 38 26.6
64.1 0.87 2 1.4 1 0.7
58.9 0.97 0 0 0 0
69.4 0.97 0 0 0 0
52 0.95 0 0 3 2
84.4 0.84 1 1 0 0
sible score irrespective of the direction of the scale.
-fatigue, functional assessment of chronic illness therapy-fatigue;
outcomes study; SF-36, short form 36 health survey.clud
inim
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0
14.9
17.7
19.9
31.5
20.9
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7.8
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Si
c
w
c
c
131V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 1 2 8 – 1 3 4syndrome; three patients were not categorized. On average, pa-
tients had moderate functional disability as defined by HAQ-DI of
1.0 [28]. Forty-five (32%) had depressed mood (CESD  10) and
F-36 PCS (mean score 38.2) andMCS (mean score 47.8) scores
were 1.2 and 0.2 SD below the US population means, respectively
(Table 1). The average fatigue level (FACIT-fatigue) was 31.6, an SD
below the general population and 44% had FACIT-fatigue  30
indicating clinically significant fatigue [29–31]. Ceiling effects (pro-
portion of patients who reported no impairment) were seen in 6%
of CESD scores, 10% of HAQ-DI scores, 13% for the SF-36 bodily
pain, 27% for SF-36 social functioning, and 41% for role limitations
due to emotional well being.
Reliability, as assessed by Cronbach’s alpha, for all legacy do-
mains was  0.70 and ranged from 0.73 (SF-36 general health) to
0.96 (SF-36 role limitations-physical).
Scores on PROMIS physical functioning domains in this sample
were about 1.0 SD worse than scores from a sample representing
theUS general population [32] (Table 2). Other scaleswere 0.2 to 0.7
SD below the general population. Ceiling effects were rare for the
PROMIS domains except for pain interference (13%) suggesting no
pain in these patients.
The average number of items completed for each CAT-admin-
istered item bank ranged from five to eight (69 CAT items per
patient for all 11 CAT item banks), and the average time to com-
plete each CAT-administered item bank ranged from 48 seconds
to 1.9 minutes per patient (average time  11.9 minutes/per pa-
tient for 11 CAT item banks; Table 3). As discussed in the Methods
section, CATs were set to administer a minimum of five items and
enough items to achieve a standard error  0.30. CATs were
stopped after amaximumof 20 items (for 8 of 11 items banks) or all
the items in a bank (12–16 items for the social satisfaction discre-
tionary, social-satisfaction roles, and sleep-impairment banks)
were administered even if the SE criterion was not met. In 8 of 11
item banks (Table 3), less than 10% of the patients reached the
maximum number of items before achieving a SE  0.30. The me-
dian SE for patients who did not complete the item bank ranged
from 0.79 to 0.91 for these items banks. For remaining three item
banks (sleep impairment, pain behavior, and pain interference),
12% to 20% of patients reached the maximum number of items
and the median SE for patients who did not complete the item
bank ranged from 0.70 to 0.88 (Table 3).
Some patients’ physical impairments required study adminis-
tration modifications whereas others experienced difficulty un-
Table 2 – Descriptive statistics of the PROMIS domains incl
items answered.
PROMIS domains
(possible score range)
N Mean Me
Anger 1.0* (27.9–89.2) 143 52.1 5
Anxiety 1.0* (31.7–88.3) 143 55.6 5
Depression 1.0* (33.5–86.4) 143 52.2 5
Fatigue 1.0* (23.0–88.4) 143 54.6 5
Pain behavior 1.0* (33.7–78.7). 143 52.4 5
Pain interference 1.0* (37.3–84.7) 143 55.1 5
Physical function 1.0 (10.1–73.4) 143 39.8 3
Sleep disturbances 1.0* (25.6–85.6) 143 51.7 5
Social satisfaction discretionary
1.0 (26.9–68.9)
143 47.1 4
Social satisfaction roles 1.0 (26.9–68.9) 142 43.4 4
Sleep impairment 1.0* (26.3–83.4) 142 51.7 5
PROMIS, patient-reported outcomes measurement information syste
* Higher scores indicate poor health-related quality of life (for other deffect is presented as “worst” score and ceiling as “best” irrespective of tderstanding the questions and required additional clarification
and time to complete the study questionnaire. For example, some
patients had one or more digital amputations and/or severe hand
contractures related to their SSc and were physically unable to
operate a mouse or computer keyboard (n  27 patients). In these
instances, the patients read the questions on the screen them-
selves, provided the answer to the coordinator, and then the co-
ordinator selected the given response in Assessment Center.
This same procedure was followed for patients who complained
of poor vision and inability to read the questions despite setting
the type font to its largest size (number of patients not cap-
tured). The mean time to administer PROMIS items was not
different between patients who required additional help versus
those who did not (P  0.0993). The number of patients who
required additional clarifications was not captured since this
was done during clinic visit. There were no differences in the
educational level or level of depressed mood in patients with
and without physical impairments (P  0.05). Ten patients (7%)
required  25 minutes to complete their assessment. Of these,
five of the patients took an average of 9.0 minutes to complete
the anger item bank. Only two of these ten patients belonged to
the physical impairment group.
Wealso explored if therewere anydifferences in thedemograph-
ics of patients who completed 56 items (first quartile) versus 81
tems (fourth quartile) or those who completed 56 items and 56
items when combining all 11 item banks. There were no statistical
differences in thepatients in regards to their sociodemographic char-
acteristics. Patients with diffuse SSc had statistically significant
worse scores on physical function, satisfaction with participation in
social roles, andsatisfactionwithparticipation indiscretionarysocial
activities (P 0.05 for all) compared to limited SSc (data not shown).
There were no other statistical differences.
The correlations in the MTMM matrix are provided in Table 4.
Validity diagonals (correlations among different methods of mea-
suring the same domain) were the largest correlations across the
row and column in every case with one exception: the PROMIS
scale (satisfaction with participation in discretionary social activ-
ities) had about the same size correlation with the legacy scale
FACIT-fatigue (r  0.62) than with the SF-36 social functioning
ounterpart. Eighty-three percent of the paired correlation t-tests
ere statistically significantly larger than relevant off-diagonal
orrelations in theMTMMmatrix, providing substantial support of
onstruct validity of the measures. The correlation between
g reliability, floor/ ceiling effects, and total number of
cores Floor Ceiling
Minimum Maximum N % N %
33 74 0 0 0 0
34 74 0 0 0 0
33 77 0 0 4 2.8
23 73 0 0 1 0.7
34 68 0 0 0 0
37 74 0 0 19 13.3
23 65 0 0 0 0
28 76 0 0 0 0
26 68 1 0.7 0 0
24 67.9 6 4.2 1 0.7
29 71 0 0 0 0
ns, a higher score indicates better health-related quality of life). Floorudin
S
dian
2
6
2
5
6
6
9
2
7
3
3
m.
omaihe direction of the scale.
ab
le
3
–
T
es
t
le
n
gt
h
p
er
it
em
ba
n
k
.
R
O
M
IS
It
em
B
an
ks
N
u
m
be
r
of
it
em
s
ad
m
in
is
te
re
d
T
im
e
(m
in
u
te
s)
N
u
m
be
r
of
it
em
s
in
th
e
it
em
ba
n
k
M
ea
n
M
ed
ia
n
M
in
im
u
m
M
ax
im
u
m
N
(%
)w
h
o
re
ac
h
ed
m
ax
im
u
m
it
em
s
M
ed
ia
n
re
li
ab
il
it
y
re
ac
h
ed
in
p
at
ie
n
ts
w
it
h
m
ax
im
u
m
sc
or
es
M
ea
n
M
ed
ia
n
M
in
im
u
m
M
ax
im
u
m
n
ge
r
1.
0*
29
6.
6
6
5
20
5
(3
)
0.
91
1.
9
1
0.
4
13
.9
n
xi
et
y
1.
0*
28
5.
5
5
5
20
2
(1
)
0.
86
0.
9
1
0.
3
8.
1
ep
re
ss
io
n
1.
0*
28
6.
2
5
5
20
8
(6
)
0.
81
0.
8
1
0.
3
8.
4
at
ig
u
e
1.
0*
95
5.
2
5
5
20
1
(1
)
0.
81
0.
9
1
0.
3
5.
9
ai
n
be
h
av
io
r
1.
0*
39
8.
0
5
5
20
28
(2
0)
0.
77
1.
2
1
0.
4
4.
6
ai
n
in
te
rf
er
en
ce
1.
0*
41
8.
1
5
5
20
26
(1
9)
0.
7
1.
1
1
0.
4
4.
6
h
ys
ic
al
fu
n
ct
io
n
1.
0
12
4
5.
3
5
5
20
1
(1
)
0.
91
1.
2
1
0.
4
5.
8
le
ep
d
is
tu
rb
an
ce
1.
0*
27
6.
3
5
5
20
6
(4
)
0.
87
0.
9
1
0.
3
4.
6
oc
ia
ls
at
is
fa
ct
io
n
d
is
cr
et
io
n
ar
y
1.
0
12
5.
5
5
5
12
7
(5
)
0.
79
1.
0
1
0.
3
7.
1
oc
ia
ls
at
is
fa
ct
io
n
ro
le
s
1.
0
14
5.
9
5
5
14
10
(7
)
0.
85
1.
0
1
0.
3
10
.4
le
ep
im
p
ai
rm
en
t
1.
0*
16
6.
9
5
5
16
17
(1
2)
0.
88
1.
0
1
0.
3
6.
3
ll
PR
O
M
IS
it
em
ba
n
ks
ab
ov
e
45
3
69
.5
56
55
20
2
11
.9
9
3.
7
79
.7
R
O
M
IS
,p
at
ie
n
t-
re
p
or
te
d
ou
tc
om
es
m
ea
su
re
m
en
t
in
fo
rm
at
io
n
sy
st
em
.
H
ig
h
er
sc
or
es
in
d
ic
at
e
p
oo
r
h
ea
lt
h
-r
el
at
ed
q
u
al
it
y
of
li
fe
(f
or
ot
h
er
d
om
ai
n
s,
a
h
ig
h
er
sc
or
e
in
d
ic
at
es
be
tt
er
h
ea
lt
h
-r
el
at
ed
q
u
al
it
y
of
li
fe
).
132 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 1 2 8 – 1 3 4HAQ-DI and PROMIS physical functioning CAT was 0.71 and be-
tween SF-36 physical functioning and PROMIS physical function-
ing was 0.82. Similarly, validity diagonals were the largest corre-
lations across rowand columnwith atmost one exception in these
matrices.
Discussion
The PROMIS initiative aims to create reliable and valid item banks
that can be used across chronic conditions. This study expands on
the original PROMIS effort by testing the performance of the
PROMIS CATs in systemic sclerosis (SSc). We have demonstrated
the feasibility of administrating CATs in patients with SSc seen in
an academic center without interrupting the flow of the clinic. In
addition, the PROMIS domains revealed construct validity against
the appropriate legacy instruments.
The time estimate is important given the PROMIS domains
were administered during the office visit with a dedicated study
coordinator and were done in patients with moderate physical
disability. Data collection occurred in the clinic usually after a
physician visit. The administration of PROMIS domains by the
study coordinator in patients with disability didn’t significantly
increase the time to complete the items. The study coordinator
was able to read the questions or help answer patients’ choices,
especially in patients with disabilities. In rare occasions, patients
initiated the study visit before seeing the physician. This may ex-
plain the time of 79.7 minutes for a single patient who likely
stopped in the middle to be interviewed and examined by the
physician but didn’t log off.
One of the objectives of PROMIS is to develop meaningful and
precise instruments while reducing respondent burden [1,2]. In
our patients with SSc, mean/median time of completion 11 CAT-
administered domains was 11.9/9.0 minutes. Patients and provid-
ers can therefore anticipate approximately 1 minute per concept
measured in clinical practice settings where PROMIS CATs are
used. In comparison, there were 91 items in the five legacy instru-
ments that captured six health constructs (physical functioning,
mental health, bodily pain, social functioning, sleep, and fatigue).
Although we did not time the completion of legacy instruments,
applying rule of thumb of completing three to five items per min-
ute [33], thesewould take approximately 18.2minutes to 30.3min-
utes for six health contructs.
By using an item bank for a particular domain that covers the
continuum of the construct, PROMIS aims to reduce the floor and
ceiling effects in PROs [2]. As an example, Rose et al. [34] used item
response theory (IRT) to construct and evaluate a preliminary item
bank for physical function (N  17,726). In simulations, a 10-item
CAT eliminated floor and decreased ceiling effects. When using
the 9-item HAQ-DI or 10-item SF-36 physical function measure,
there were significant floor and ceiling effects. In our study, the
presence of floor effectwasminimal but a higher ceiling effectwas
seen in the assessment of pain interference (13%), which sug-
gested a large proportion of patients reported no pain. Similar
ceiling effect was seen with the SF-36 bodily pain scale (13%). For
other domains, the ceiling effectswere nonexistent to less than 3%
with PROMIS domains compared with the legacy instruments.
Lack of high proportion of patients with floor/ceiling effects on
other measures reflects moderate-to-severe physical, mental and
social impact of SSc.
We assessed construct validity of the PROMIS domains and
legacy measures. All correlations between PROMIS domains and
corresponding legacy measures were large and in the hypothe-
sized direction; the absolute value of these correlations ranged
from 0.61 to 0.82. The correlations of PROMIS scale (satisfaction
with participation in discretionary social activities) correlated as
highly with the legacy item FACIT-fatigue (r  0.62) as it did with
SF-36 social functioning scale (r 0.61). This is probably due to the
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participate in social activities.
With the exception of physical functionwhich does not include
a time frame and the social health banks that reference “lately,” all
PROMIS item banks reference the past 7 days. In comparison,
SF-36 scales and MOS sleep scale use 4-week recall period. In a
previous study, researchers compare acute (1-week recall) and
standard (4-week recall) versions of the SF-36 scale scores in 142
patientswith asthma [35]. The acute form scoreswere reliable, the
scales conform to assumptions underlying their scoring and scal-
ing, and scales had factor content similar to the standard version.
This, however, needs to be validated in other chronic diseases,
including different arthritides.
Majority of the patients were able to achieve the pre-specified
SE 0.30when completing CAT-administered itembank. In 8 of 11
tem banks (Table 3),1% to 7% of the patients reached the maxi-
um number of items before achieving a SE0.30. For remaining
three item banks (sleep impairment, pain behavior, and pain in-
terference), 12% to 20% of patients reached themaximumnumber
of items and likely reflects lack of pain in majority of these pa-
tients.
Our study has strengths. To our knowledge, this is the first
application of CAT-administered PROMIS items in clinical setting
without disrupting the flow of the clinic. Second, this study ad-
ministered legacy instruments and PROMIS domains allowing us
to assess the construct validity of PROMISwithin SSc, a disease not
specifically targeted in the instrument development.
Our study has limitations. First, we did not assess responsive-
ness of the PROMIS banks and legacy instruments. This will re-
quire longitudinal data. Second, we only included five legacy in-
struments representing six health domains in this study whereas
we included all 11 PROMIS item banks. This is because the original
objective of the study was to assess minimally important differ-
ences for OMERACT-endorsed outcomes measures in SSc. Third,
we only evaluated the feasibility of PROMIS item banks in the re-
search clinical setting. We had a dedicated study coordinator who
was responsible for helping patients complete the PROMIS do-
mains and providing legacy instruments. We had dedicated clinic
area and the administrators were supportive of our research ob-
jectives. If these measures are to be used in routine clinical prac-
tice, that task would fall to clinical staff (e.g., nurse, receptionist),
which might drastically impact clinic flow. Fourth, we didn’t eval-
uate differential item functioning because we administered the
CATs in this study. We made an assumption that the items per-
formance was similar in this sample to prior PROMIS administra-
tions. Previous analyses of differential item functioning in PROMIS
have indicated that the items are generally robust to age, gender,
and education [36,37]. Ongoing work is evaluating DIF by other
ubgroups (e.g., by disease group). If future studies show that SSc
atients respond differently to PROMIS items than the large PRO-
Table 4 – MTMM correlation matrix.
PROMIS instrument (N  67) CESD FACIT-fatigue
Depression 1.0 0.67 0.44
Fatigue 1.0 0.59 0.76
Pain behavior 1.0 0.44 0.53
Physical function 1.0 0.46 0.72
Sleep disturbance 1.0 0.50 0.37
Social satisfaction discretionary 1.0 0.56 0.62
Validity diagonal correlations are not highlighted.
CESD, center for epidemiologic studies depression (10 item scale);
HAQ-DI, health assessment questionnaire-disability index; MTMM,m
information system; SF-36, short form 36 health survey; VT, vitalit
medical outcomes study sleep problem index (9 item).IS calibration sample, then the item parameters used for thisstudy would be suboptimal and the study findings would need to
be re-evaluated. Fifth, we didn’t formally evaluate for cognitive
function in this patient group. Cognitive impairment may have
contributed to the longer time ( 25 minutes) to complete their
assessment. Finally, this study did not assess the clinical utility of
themeasures. As an example, legacy instruments such as HAQ-DI
and CESD are used for clinical decisionmaking [21,28]. Rather, the
objective of the study was to assess construct validity; other stud-
ies are needed to determine appropriate score cut points and link-
age of legacy instrument scores with PROMIS item banks and its
applicability in clinical decision making.
In conclusion, our study provides support for the construct va-
lidity of CAT-administered PROMIS item banks and reports that is
feasible to administer them in a clinical practice with support
staff. Studies are underway to assess clinical utility and respon-
siveness of the PROMIS item banks.
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